
Patent Ductus Arteriosus (PDA) Closure is a procedure to seal an abnormal opening between the two major blood vessels leading from the heart: the aorta and the pulmonary artery. In a normal heart, this vessel (the ductus arteriosus) closes naturally shortly after birth; if it stays open, it can cause too much blood to flow to the lungs, straining the heart. While surgical ligation remains necessary for specific cases, transcatheter (minimally invasive) techniques have become the gold standard for most children and adults.
Heart failure symptoms such as fatigue or shortness of breath.
Poor weight gain or difficulty feeding in infants.
Evidence of left-sided heart enlargement or significant heart overload.
High pressure in the lung arteries (Pulmonary Hypertension).
High risk of endocarditis (infection of the heart lining) due to the defect.
Transcatheter PDA Closure: A minimally invasive method using a groin catheter to "plug" the hole with a device.
Surgical Ligation: Traditional approach where a surgeon ties off the vessel with sutures or clips via a small incision.
Device Occlusion: Deployment of "soft" low-profile mesh devices (occluders) to block the abnormal flow.
Thoracotomy: A surgical technique used primarily for premature infants or complex PDA shapes.
Hybrid Approach: A combination of surgery and catheterization used for unique anatomical challenges.
Catheter Access: A thin tube is guided through a vein in the groin (femoral vein) to reach the heart.
Device Positioning: Under X-ray guidance, a tiny mesh "plug" is moved into the ductus arteriosus.
Permanent Sealing: The device blocks the hole, and over time, heart tissue grows over the mesh.
Surgical Clipping: In surgical cases, the vessel is physically tied off to prevent blood from passing through.
Monitoring: Real-time imaging ensures the device is perfectly positioned before finishing the procedure.
Fasting for 8-12 hours before the scheduled procedure.
Blood tests, ECG, and chest X-rays to assess overall cardiac health.
Adjusting current medications as directed by the medical team.
Discussing any allergies, particularly to nickel (used in some devices) or contrast dye.
Arranging for a hospital stay (ranging from a few hours to a few days depending on the method).
Echocardiogram (TTE) to determine the size and shape of the PDA.
Cardiac Catheterization to measure lung pressures and map the vessel anatomy.
Chest X-ray to check for heart enlargement or fluid in the lungs.
ECG to monitor the heart's electrical rhythm and check for strain.
Pulse oximetry to evaluate oxygen levels in the blood.
Short hospital stay, often allowing patients to go home the same day or after one night.
Resume normal activity usually within a week; avoid heavy lifting for a few days.
Regular follow-up visits with a cardiologist to ensure the device remains in place.
Significant improvement in feeding, growth milestones, and energy levels.
Once closed, it is considered a permanent cure with no further procedures typically required.
Restores normal blood flow and prevents oxygen-rich blood from flooding the lungs.
Protects the lungs from permanent damage caused by high blood pressure.
Allows infants to reach growth milestones and maintain healthy weight gain.
Reduces the risk of heart failure and enlargement of the heart's chambers.
Provides a long-term cure with extremely high technical success rates (98% to 99%).